Javascript must be enabled to continue!
Long-term results of transcatheter closure of large secundum atrial septal defect: comparison of intraoperative device closure
View through CrossRef
Background
Both Transcatheter device closure (TCDC) or intraoperative device closure (IODC) have emerged as new minimally invasive alternatives to the classic surgery in the treatment of secundum atrial septal defect (ASD). However, the long-term safety and efficacy by the two methods for closuring large particularly huge ASD remains uncertain. Present study sought to investigate and compare the long-term clinical outcomes by using TC DC and IODC for closure of large-to-huge ASD.
Methods
A total 92 patients with large-to-huge ASD (a defect diameter of ≥30 mm), treated from January 2003 to Dec 2009, were included in this study. All the patients have been followed up until Dec 2010. The patients were assigned to either TCDC or IODC group according to the patients′ or their parents′ preference. Baseline physical exams, chest roentgenography, electrocardiography, and echocardiography were performed pre-procedure and at each follow-up visit.
Results
42 patients underwent TCDC and 50 patients received IODC by using Amplatzer septal occluder (ASO). The average diameter of ASD was similar in the two groups (35.2±4.8 mm vs 34.9±4.4 mm, p>0.05). The immediate procedural success rate was 92.9% for TCDC and 98.0% for IODC (p=0.328). The peri-procedural complication rate was 9.5% for TCDC and 28.0% for IODC p<0.05). The mean length of hospital stay was 6.5±2.7 days for TCDC and 11.9±3.8 days for IODC (p<0.001). At the follow-up of 4.5±2.1 years, there were no cardiac deaths and late complications such as infective endocarditis, transient ischemic attack, ischemic stroke or cerebral haemorrhage, there were no ASO dislodge, valvular or venous compromise and atrial wall erosion by ASO in both group, the residual shunt was not documented in TCDC and only two cases of trivial residual shunt found in IODC.
Conclusions
Present study confirmed the long-term safety and efficacy by using ASO for closure of large-to-huge ASD either by TCDC or IODC. However, the acute complication rate was lower and the length of hospital stay was shorter by TCDC.
Title: Long-term results of transcatheter closure of large secundum atrial septal defect: comparison of intraoperative device closure
Description:
Background
Both Transcatheter device closure (TCDC) or intraoperative device closure (IODC) have emerged as new minimally invasive alternatives to the classic surgery in the treatment of secundum atrial septal defect (ASD).
However, the long-term safety and efficacy by the two methods for closuring large particularly huge ASD remains uncertain.
Present study sought to investigate and compare the long-term clinical outcomes by using TC DC and IODC for closure of large-to-huge ASD.
Methods
A total 92 patients with large-to-huge ASD (a defect diameter of ≥30 mm), treated from January 2003 to Dec 2009, were included in this study.
All the patients have been followed up until Dec 2010.
The patients were assigned to either TCDC or IODC group according to the patients′ or their parents′ preference.
Baseline physical exams, chest roentgenography, electrocardiography, and echocardiography were performed pre-procedure and at each follow-up visit.
Results
42 patients underwent TCDC and 50 patients received IODC by using Amplatzer septal occluder (ASO).
The average diameter of ASD was similar in the two groups (35.
2±4.
8 mm vs 34.
9±4.
4 mm, p>0.
05).
The immediate procedural success rate was 92.
9% for TCDC and 98.
0% for IODC (p=0.
328).
The peri-procedural complication rate was 9.
5% for TCDC and 28.
0% for IODC p<0.
05).
The mean length of hospital stay was 6.
5±2.
7 days for TCDC and 11.
9±3.
8 days for IODC (p<0.
001).
At the follow-up of 4.
5±2.
1 years, there were no cardiac deaths and late complications such as infective endocarditis, transient ischemic attack, ischemic stroke or cerebral haemorrhage, there were no ASO dislodge, valvular or venous compromise and atrial wall erosion by ASO in both group, the residual shunt was not documented in TCDC and only two cases of trivial residual shunt found in IODC.
Conclusions
Present study confirmed the long-term safety and efficacy by using ASO for closure of large-to-huge ASD either by TCDC or IODC.
However, the acute complication rate was lower and the length of hospital stay was shorter by TCDC.
Related Results
ASSA13-15-6 Transcatheter Closure of Patent Ductus Arteriosus with Severe Pulmonary Hypertension Using Domestic Occluder in Adults
ASSA13-15-6 Transcatheter Closure of Patent Ductus Arteriosus with Severe Pulmonary Hypertension Using Domestic Occluder in Adults
Background
To evaluate the clinical efficacy of transcatheter closure of patent ductus arteriosus (PDA) with severe pulmonary hypertention using domestic occluder...
P920Understanding arrhythmia mechanisms in patients with atrial septal defects
P920Understanding arrhythmia mechanisms in patients with atrial septal defects
Abstract
Background
Atrial arrhythmias represent a major cause of morbidity and hospitalization in patients with atrial septal d...
Effects of Transcatheter Atrial Septal Defect Closure in Elderly Patients with Long-Standing Persistent Atrial Fibrillation
Effects of Transcatheter Atrial Septal Defect Closure in Elderly Patients with Long-Standing Persistent Atrial Fibrillation
Abstract
Purpose
Although the safety and efficacy of transcatheter atrial septal defect (ASD) closure has been reported in elderly patients, postprocedural outcomes in eld...
Cardiac remodeling after atrial septal defects device closure
Cardiac remodeling after atrial septal defects device closure
AbstractBackgroundTrans‐catheter device closure of secundum type atrial septal defects (ASDs) has now become the treatment of choice. Device closure affects the hemodynamics and fu...
e0486 Transcatheter closure of no rim large atrial septal defect with amplatzer occluders: technical considerations, safety and feasibility
e0486 Transcatheter closure of no rim large atrial septal defect with amplatzer occluders: technical considerations, safety and feasibility
Backgrounds
Transcatheter closuring no rim or large atrial septal defect (ASD) with Amplatzer occluding device (AOD) was technically challenged. The present study...
Atrial Septal Abnormalities and Cryptogenic Stroke: A Cross-Sectional
Study
Atrial Septal Abnormalities and Cryptogenic Stroke: A Cross-Sectional
Study
Background:
Cryptogenic stroke, whose underlying pathology is unknown, accounts
for 30-40% of all ischemic strokes. Studies have mentioned the association between atrial septal
abn...
Transhepatic device closure of large atrial septal defect
Transhepatic device closure of large atrial septal defect
AbstractTranscatheter closure of secundum-type atrial septal defects has become the treatment of choice in the majority of cases. Femoral venous access is the standard rout for dev...
INTERVENTIONAL THERAPY OF MULTIPLE ATRIAL SEPTAL DEFECTS
INTERVENTIONAL THERAPY OF MULTIPLE ATRIAL SEPTAL DEFECTS
Objectives
To evaluate the safety and efficiency of transactheter closure of multiple atrial septal defects.
Met...

